Hypoglycemia

Clinical Diabetes

Volumn 26, Issue 4, 2008, Pages 170-173

  Fowler, Michael J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; INSULIN; INSULIN DERIVATIVE; ISOPHANE INSULIN;

CONTINUING EDUCATION; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; REVIEW; SELF CARE;

EID: 54249115398     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.26.4.170     Document Type: Review

References (13)

1. Cryer PE: Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia 45:937-948, 2002
2. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 26:1902-1912, 2003
3. Havlin CE, Cryer PE: Hypoglycemia: the limiting factor in the management of insulin-dependent diabetes mellitus. Diabetes Educ 14:407-411, 1988
4. DCCT Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. UKPDS Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
6. Cryer PE: Hypoglycemia, functional brain failure, and brain death. J Clin Invest 117:868-870, 2007
7. Segel SA, Paramore DS, Cryer PE: Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51:724-733, 2002
8. American Diabetes Association: Standards of medical care in diabetes - 2008 [Position Statement]. Diabetes Care 31 (Suppl. 1):S12-S54, 2008
9. Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, Jovanovic L: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 29:44-50, 2006
10. Home P, Bartley P, Russell-Jones D, Hanaire-Broutin H, Heeg JE, Abrams P, Landin-Olsson M, Hylleberg B, Lang H, Draeger E: Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial. Diabetes Care 27:1081-1087, 2004
11. Pickup JC, Renard E: Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 31 (Suppl. 2):S140-S145, 2008
12. Raskin P, Klaff L, Bergenstal R, Halle JP, Donley D, Mecca T: A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care 23:1666-1671, 2000
13. Hunger-Dathe W, Braun A, Muller UA, Schiel R, Femerling M, Risse A: Insulin pump therapy in patients with type 1 diabetes mellitus: results of the Nationwide Quality Circle in Germany (ASD) 1999-2000. Exp Clin Endocrinol Diabetes 111:428-434, 2003